MENU
ANAB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AnaptysBio (ANAB) Earnings Date & Reports
AnaptysBio Inc is a clinical-stage biotechnology company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ANAB is expected to report earnings to fall 100.98% to -5 cents per share on November 10
Q3'26
Est.
$-0.05
Q2'26
Beat
by $5.24
Q1'26
Missed
by $0.88
Q4'25
Beat
by $0.71
Q3'25
Beat
by $1.92
The last earnings report on September 22 showed earnings per share of $5.11, beating the estimate of -12 cents. With 148.15K shares outstanding, the current market capitalization sits at 1.52B.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a provider of therapeutic antibodies for inflammation and immuno-oncology
Industry Biotechnology
Industry
Biotechnology
Address
10770 Wateridge Circle
Phone
+1 858 362-6295
Employees
104
Web
https://www.anaptysbio.com